Gilead in pact for anti-inflammatory drugs in deal worth up to $1.7 billion



Gilead in pact for anti-inflammatory drugs in deal worth up to $1.7 billion



Source link

  • Related Posts

    Will 2025 be the year of artificial intelligence (AI) agents? Nvidia CEO Jensen Huang thinks so.

    Hearing what industry leaders have to say about the future of artificial intelligence (AI) is key to being a successful investor. One of the leaders of AI is Nvidia‘s (NASDAQ:…

    Factbox-US companies tweak diversity policies as challenges mount By Reuters

    (Reuters) – Meta Platforms (NASDAQ: ) and Amazon.com (NASDAQ: ) have joined a growing number of U.S. companies in lowering their diversity, equity, and inclusion (DEI) standards, which are intended…

    Leave a Reply

    Your email address will not be published. Required fields are marked *